Manulife (Manufacturers Life Insurance)’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.1K Hold
69,252
﹤0.01% 2872
2025
Q1
$53.2K Sell
69,252
-793
-1% -$609 ﹤0.01% 2821
2024
Q4
$89.3K Hold
70,045
﹤0.01% 2844
2024
Q3
$145K Hold
70,045
﹤0.01% 2767
2024
Q2
$267K Sell
70,045
-2,217
-3% -$8.45K ﹤0.01% 2472
2024
Q1
$343K Buy
72,262
+2,097
+3% +$9.94K ﹤0.01% 2335
2023
Q4
$300K Hold
70,165
﹤0.01% 2412
2023
Q3
$217K Hold
70,165
﹤0.01% 2556
2023
Q2
$316K Buy
70,165
+35,867
+105% +$161K ﹤0.01% 2323
2023
Q1
$195K Hold
34,298
﹤0.01% 2578
2022
Q4
$191K Buy
34,298
+31
+0.1% +$173 ﹤0.01% 2593
2022
Q3
$224K Hold
34,267
﹤0.01% 2512
2022
Q2
$178K Hold
34,267
﹤0.01% 2716
2022
Q1
$238K Buy
+34,267
New +$238K ﹤0.01% 2650
2021
Q2
Sell
-5,516
Closed -$239K 3273
2021
Q1
$239K Buy
5,516
+227
+4% +$9.84K ﹤0.01% 2770
2020
Q4
$378K Buy
+5,289
New +$378K ﹤0.01% 2376